Barclays PLC Nektar Therapeutics Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $189,525 - $322,175	-17,500 Reduced 69.44%	7,700 $104,000
Q4 2020 Feb 11, 2021	BUY	$15.77 - $19.03 $302,784 - $365,376	19,200 Added 320.0%	25,200 $428,000
Q3 2020 Nov 12, 2020	SELL	$16.59 - $24.79 $18,249 - $27,269	-1,100 Reduced 15.49%	6,000 $100,000
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $915,498 - $1.27 Million	-54,300 Reduced 88.44%	7,100 $164,000
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $1.21 Million - $2.35 Million	-83,900 Reduced 57.74%	61,400 $1.1 Million
Q4 2019 Feb 10, 2020	BUY	$15.87 - $23.12 $112,677 - $164,152	7,100 Added 5.14%	145,300 $3.14 Million
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $610,451 - $1.31 Million	-36,100 Reduced 20.71%	138,200 $2.52 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $1.25 Million - $1.47 Million	40,400 Added 30.17%	174,300 $6.2 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $258,956 - $380,070	-8,200 Reduced 5.77%	133,900 $4.5 Million
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $1.11 Million - $2.07 Million	-36,600 Reduced 20.48%	142,100 $4.67 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $4 Million - $5.9 Million	-86,100 Reduced 32.52%	178,700 $10.9 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $8.69 Million - $19.6 Million	187,900 Added 244.34%	264,800 $12.9 Million
Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $1.9 Million - $3.59 Million	-33,100 Reduced 30.09%	76,900 $8.17 Million
Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $108,194 - $284,350	-4,700 Reduced 4.1%	110,000 $6.57 Million
Q3 2017 Nov 14, 2017	BUY	$17.79 - $24.0 $2.04 Million - $2.75 Million	114,700	114,700 $2.75 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.8 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$14.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$12.2 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.74 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.56 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $174M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account